<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), deletions of chromosome 7 or 7q are common and correlate with a poor prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>The relevant genes on chromosome 7 are unknown </plain></SENT>
<SENT sid="2" pm="."><plain>We report here that EZH2, located at 7q36.1, is frequently targeted in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Analysis of EZH2 deletions, missense and frameshift mutations strongly suggests that EZH2 is a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor </plain></SENT>
<SENT sid="4" pm="."><plain>As EZH2 functions as a <z:chebi fb="0" ids="15358">histone</z:chebi> methyltransferase, abnormal <z:chebi fb="0" ids="15358">histone</z:chebi> modification may contribute to epigenetic deregulation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>